Table 4.
Differences in protein expression between African American and Caucasian American human prostate tumor tissues.
| Identified Proteins | Gene Name | Log2 | P-value | Q-value |
|---|---|---|---|---|
| Phosphoacetylglucosamine mutase | PGM3 | -5.46 | 2.97E-04 | 1.07E-01 |
| Pyrroline-5-carboxylate reductase 1, mitochondrial | PYCR1 | -2.38 | 2.98E-04 | 1.07E-01 |
| Lysosomal alpha-glucosidase | GAA | -2.10 | 2.11E-04 | 1.07E-01 |
| Heterogeneous nuclear ribonucleoprotein M | HNRNPM | -1.63 | 2.81E-04 | 1.07E-01 |
| Transaldolase | TALDO1 | -1.17 | 3.52E-04 | 1.07E-01 |
| Heterogeneous nuclear ribonucleoprotein L | HNRNPL | -1.13 | 4.00E-04 | 1.07E-01 |
| Gamma-glutamylcyclotransferase | GGCT | -5.78 | 1.64E-03 | 1.26E-01 |
| Pro-cathepsin H | CTSH | -3.91 | 1.64E-03 | 1.26E-01 |
| Puromycin-sensitive aminopeptidase | NPEPPS | -3.70 | 1.66E-03 | 1.26E-01 |
| Ubiquitin carboxyl-terminal hydrolase 5 | USP5 | -3.29 | 1.23E-03 | 1.26E-01 |
| Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial | SUCLG2 | -3.08 | 1.32E-03 | 1.26E-01 |
| Beta-hexosaminidase subunit beta | HEXB | -2.97 | 9.89E-04 | 1.26E-01 |
| Protein NDRG1 | NDRG1 | -2.42 | 7.10E-04 | 1.26E-01 |
| Metalloreductase STEAP4 | STEAP4 | -2.36 | 7.12E-04 | 1.26E-01 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 | DDAH2 | -2.05 | 9.39E-04 | 1.26E-01 |
| Cathepsin D | CTSD | -1.89 | 7.01E-04 | 1.26E-01 |
| Coatomer subunit alpha | COPA | -1.85 | 1.71E-03 | 1.26E-01 |
| GDP-L-fucose synthase | TSTA3 | -1.84 | 1.64E-03 | 1.26E-01 |
| Proteasome subunit beta type-5 | PSMB5 | -1.72 | 1.65E-03 | 1.26E-01 |
| Elongation factor Tu, mitochondrial | TUFM | -1.37 | 1.23E-03 | 1.26E-01 |
| Endoplasmin | HSP90B1 | -1.00 | 1.72E-03 | 1.26E-01 |
| Lipoma-preferred partner | LPP | -0.04 | 1.59E-03 | 1.26E-01 |
The significance threshold was set at 10% FDR, but proteins with Q < 0.13 are shown. The Log2 fold change is the base 2 logarithm of the ratio of mean tumor expression to mean non-malignant expression.